BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Equibles//Investor Events//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
NAME:Inhibrx Biosciences\, Inc. (INBX) investor events
X-WR-CALNAME:Inhibrx Biosciences\, Inc. (INBX) investor events
DESCRIPTION:Earnings calls and investor events for Inhibrx Biosciences\, In
 c. (INBX)\, from Equibles.
X-WR-CALDESC:Earnings calls and investor events for Inhibrx Biosciences\, I
 nc. (INBX)\, from Equibles.
REFRESH-INTERVAL;VALUE=DURATION:PT6H
X-PUBLISHED-TTL:PT6H
BEGIN:VEVENT
UID:7afc5ac4-f5f6-48d5-b8a9-fa61ac1def68@equibles.com
DTSTAMP:20260617T190630Z
DTSTART;VALUE=DATE:20251114
DTEND;VALUE=DATE:20251115
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Inhibrx Biosciences\, Inc. (INBX) Earnings Call\, FY2025 Q3
DESCRIPTION:The start time has not been announced.\nWebcast: https://inhibr
 xbiosciences.investorroom.com/events-and-presentations?item=51
URL:https://equibles.com/stocks/inbx/calls/2025-q3
END:VEVENT
BEGIN:VEVENT
UID:2d1b75e2-4d26-424e-b9aa-ca58af154f01@equibles.com
DTSTAMP:20260706T232943Z
DTSTART;VALUE=DATE:20251122
DTEND;VALUE=DATE:20251123
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Inhibrx Biosciences\, Inc. (INBX) Annual General Meeting: 2025 Soci
 ety for NeuroOncology Annual Meeting
DESCRIPTION:2025 Society for NeuroOncology Annual Meeting\nThe start time h
 as not been announced.\nWebcast: https://inhibrxbiosciences.investorroom.c
 om/events-and-presentations?item=53
END:VEVENT
BEGIN:VEVENT
UID:02343011-02eb-4848-b9f5-ba3b90915d44@equibles.com
DTSTAMP:20260706T232947Z
DTSTART;VALUE=DATE:20260225
DTEND;VALUE=DATE:20260226
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Inhibrx Biosciences\, Inc. (INBX) Conference: British Sarcoma Group
  Annual Conference 2026
DESCRIPTION:British Sarcoma Group Annual Conference 2026\nThe start time ha
 s not been announced.\nWebcast: https://inhibrxbiosciences.investorroom.co
 m/events-and-presentations?item=54
END:VEVENT
BEGIN:VEVENT
UID:77d39787-0482-432d-9a61-372b77e26d43@equibles.com
DTSTAMP:20260617T191107Z
DTSTART;VALUE=DATE:20260421
DTEND;VALUE=DATE:20260422
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Inhibrx Biosciences\, Inc. (INBX) Earnings Call\, FY2026 Q1
DESCRIPTION:The start time has not been announced.\nWebcast: https://app.we
 binar.net/JqrDlM8B4ak
URL:https://equibles.com/stocks/inbx/calls/2026-q1
END:VEVENT
BEGIN:VEVENT
UID:ba0e4f95-4117-4582-b3ed-1a463465467d@equibles.com
DTSTAMP:20260706T232946Z
DTSTART;VALUE=DATE:20260530
DTEND;VALUE=DATE:20260531
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Inhibrx Biosciences\, Inc. (INBX) Annual General Meeting: 2026 Amer
 ican Society of Clinical Oncology (ASCO) Annual Meeting
DESCRIPTION:2026 American Society of Clinical Oncology (ASCO) Annual Meetin
 g\nThe start time has not been announced.\nWebcast: https://inhibrxbioscie
 nces.investorroom.com/events-and-presentations?item=57
END:VEVENT
BEGIN:VEVENT
UID:241a8622-9872-428a-a0c5-8b1b87fad2cb@equibles.com
DTSTAMP:20260909T043823Z
DTSTART:20260908T120000Z
DTEND:20260908T130000Z
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Inhibrx Biosciences\, Inc. (INBX) Earnings Call\, FY2026 Q2
DESCRIPTION:Webcast: https://app.webinar.net/4712m15mpwW
URL:https://equibles.com/stocks/inbx/calls/2026-q2
END:VEVENT
END:VCALENDAR